cholest-5-ene-3 beta,26-diol has been researched along with diosgenin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kisic, A; Ni, Y; Schroepfer, GJ; Wilson, WK | 1 |
| Alessandrini, L; Ciuffreda, P; Santaniello, E; Terraneo, G | 1 |
2 other study(ies) available for cholest-5-ene-3 beta,26-diol and diosgenin
| Article | Year |
|---|---|
Inhibitors of sterol synthesis. Tritium-labeled 26-hydroxycholesterol of high specific activity from a byproduct of the Clemmensen reduction of diosgenin.
Topics: Deuterium; Diosgenin; Hydroxycholesterols; Magnetic Resonance Spectroscopy; Mass Spectrometry; Molecular Conformation; Oxidation-Reduction; Tritium | 1994 |
Clemmensen reduction of diosgenin and kryptogenin: synthesis of [16,16,22,22,23,23-(2)H(6)]-(25R)-26-hydroxycholesterol.
Topics: Deuterium; Diosgenin; Hydrogenation; Hydroxycholesterols; Oxidation-Reduction; Sterols | 2004 |